Etiome
Founded 2021 · 26 employees on LinkedIn · 1 known investors
Find your way into Etiome
803 people in our graph share verified history with the Etiome team — schools, employers, funds. One of them is your warm intro.
Paul Fieldingunlockedknows Scott Lipnick · together at UCLA (overlapped)
knows the team · via Flagship Pioneering
×4knows the team · via Broad Institute of MIT and Harvard
knows the team · via Massachusetts General Hospital
knows the team · via Cellarity
knows the team · via Harvard Medical School
Etiome develops stage-specific medicines by applying single-cell omics and artificial intelligence to map disease progression and identify disease-modifying targets at early biological inflection points for preemptive intervention. Founded in 2021 out of Flagship Pioneering's Preemptive Health and Medicine initiative, the biotech company focuses on treating or reversing disease before it advances to later stages.
Founders & leadership
KV
Katharine von HerrmanninCo-founder
AK
Avak Kahvejianin𝕏Founding Team; Founding CEOAvak Kahvejian is founding CEO of Etiome, a biotech company developing stage-specific medicines using single-cell omics and AI to identify disease-modifying targets. He previously worked at Flagship Pioneering, where he conceived and launched platform companies focused on novel biological mechanisms and biotechnologies.
NA
Noubar AfeyanFounding Team
SL
Scott LipnickinFounding TeamScott Lipnick is a member of the founding team at Etiome, a biotech company developing stage-specific medicines using single-cell omics and AI to identify disease-modifying targets for early intervention. He previously worked at Flagship Pioneering, where he collaborated on the Preemptive Health and Medicine initiative and co-founded multiple companies focused on preemptive health approaches.
TS
Torben Straight NisseninFounding Team; Board DirectorExecutive Officer, Director at Rubius Therapeutics
YE
Yann EchelardFounding Team; Chief Operating Officer
AR
Adrian RawcliffeinCEO-Partner & Chief Executive Officer
JL
Jean LachowiczinChief Scientific Officer
SE
Sandi EngleHead of Biology
AS
Artem SokolovinHead of Computational Biology
Investors · 1
In the news
Frequently asked questions
- What does Etiome do?
- Etiome develops stage-specific medicines by applying single-cell omics and artificial intelligence to map disease progression and identify disease-modifying targets at early biological inflection points for preemptive intervention. Founded in 2021 out of Flagship Pioneering's Preemptive Health and Medicine initiative, the biotech company focuses on treating or reversing disease before it advances to later stages.
- Who founded Etiome?
- Etiome was founded by Katharine von Herrmann, Avak Kahvejian, Noubar Afeyan, Scott Lipnick, Torben Straight Nissen, Yann Echelard in 2021.
- Who are Etiome's investors?
- Etiome's investors include Flagship Pioneering.